The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE- Pepsi, Select Comfort, Nokia, American Express

Thu, 18th Apr 2013 11:37

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s)

April 18 (Reuters) - Some U.S. stocks to watch on Thursday:

FUTURES SIGNAL HIGHER OPEN

Index futures pointed to a slightly higher open on WallStreet. Futures for the S&P 500, the Dow Jones andthe Nasdaq 100 were up 0.1 to 0.2 percent.

** PEPSICO INC, Wednesday close $78.85, up 1 pctpremarket

The maker of Pepsi sodas, Tropicana juices, Frito-Lay snacksand Quaker oatmeal reported better-than-expected first-quarterearnings, as price increases helped margins.

** NOKIA , Wednesday close $3.58, down 13pct premarket

A big fall in sales of the company's basic phonesovershadowed a stronger performance from its Lumia smartphonesin the first quarter, and it said it expected operating marginsto deteriorate.

Chief Executive Stephen Elop said tougher competition wasthe main reason behind the fall in sales of regular mobilephones.

** AMERICAN EXPRESS CO, Wednesday close $64.13, down1.5 pct after market

The credit card company's first-quarter revenue came inbelow analysts' expectations as cardmember spending growthremained muted.

** UNITEDHEALTH GROUP INC, Wednesday close $62.03

The nation's largest health insurer said its first-quarterprofit had fallen, in part because of lower government paymentsfor its private Medicare services and prescription plans forolder Americans.

** SELECT COMFORT CORP, Wednesday close $17.56,down 15 pct after market

The specialty mattress maker said it would revert to itsearlier marketing strategy after a shift in advertising reducedexposure of its products to already cautious customers and hitsales.

** ALLISON TRANSMISSION HOLDINGS INC, Wednesdayclose $21.16, up 9 pct after market

The maker of fully-automatic transmissions said late onWednesday that investment funds affiliated with Carlyle Group LP and Onex Corp would not proceed with a secondaryoffering of Allison Transmission's common stock due to marketconditions.

** SANDISK CORP, Wednesday close $55.72, up 3 pctpremarket

The company raised its forecast for revenue this year andsaid it expects higher prices for its NAND memory chips, whichare used in smartphones and tablets.

** EBAY INC, Wednesday close $56.10, down 3.6 pctpremarket

The e-commerce company gave a disappointing earningsforecast for the second quarter and said Europe was weak,pushing its shares lower in after-hours trade.

** ROPER INDUSTRIES INC, Wednesday close $120.54,

The diversified U.S. manufacturer said it would buyhealthcare services company Managed Health Care Associates Incfor $1 billion in an all-cash deal to expand its presence in thehealthcare market.

** THERAVANCE INC, Wednesday close $28.01, up 18pct after market

An advisory panel to the U.S. Food and Drug Administrationhas recommended that the agency approve an experimentaltreatment for smoking-related lung damage made by Britain'sGlaxoSmithKline Plc and Theravance.

** VALE SA ADR >, Wednesday close $15.82,up 2.5 pct after market

The top global iron ore miner's mega ship called at a portin eastern China this week, marking the first entry of thevessels since Beijing banned them in January2012.

** KEYCORP, Friday close $9.53

The bank reported first-quarter results which marginallybeat estimates helped by lower expenses and commercial loangrowth.

** ACCURAY INCORPORATED, Wednesday close $4.44

The radiation oncology company said it started on March 19voluntary recalls of two separate components from itsradiotheraphy product line CyberKnife. "The affected parts aremanufactured by third-party suppliers and are being removed fromthe system because they failed to meet the company'sspecifications and standards for quality," Accuray said in astatement.

** SINOVAC BIOTECH LTD, Wednesday close $4.13, up 2pct premarket

The pharmaceutical company said the Mexico health regulatorgranted marketing approval to its seasonal flu vaccine, namedAnflu. Sinovac said the certificate of commercial approval isvalid from April 1, 2013 to April 1, 2018. (Compiled by Aditi Shrivastava; Editing by Joyjeet Das)

More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.